Probióticos, prebióticos y simbióticos en alergia y sus aplicaciones clínicas. Dr. Bruno Paes Barreto

SLaai 203 views 39 slides Aug 31, 2018
Slide 1
Slide 1 of 39
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39

About This Presentation

Probióticos, prebióticos y simbióticos en alergia y sus aplicaciones clínicas. Dr. Bruno Paes Barreto


Slide Content

Prebióticos, probióticos y
simbióticos en alergia y sus
aplicaciones clínicas
Bruno Paes Barreto
Doutor em Ciências pela Universidade Federal de São Paulo/Brasil
Professor Adjunto de Pediatria da Universidade do Estado do Pará/Brasil
Membro do Comitê de Alergias na Infância da Associação Brasileira de Alergia

I certify that all my affiliations with or without financial
involvement in any organization or entity with respect to the
subject matter or materials discussed, are fully expressed below:

DISCLOSURES/2012
Advisory Board – Probiotics
• Danone
• Sanofi-Aventis
Speaker
• Mantecorp-
Farmasa
• Takeda

LESSON PLAN
•Concepts
•Theoretical basis
•Clinical applicability
–Immune regulation
–Allergic Diseases
•Prevention
•Treatment

LESSON PLAN
•Concepts
•Theoretical basis
•Clinical applicability
–Immune regulation
–Allergic Diseases
•Prevention
•Treatment

HYGIENE HYPOTHESIS: PROPOSED CHANGES
ISOLAURI, 2010
PAST PRESENT TIME

“WE ARE MORE HUMAN OR MORE
BACTERIA?”
100 trillion
Genome 10x
greater than
the human
Metabolic
capacity equal
to the liver
Different
strains
Inter-species
communication
with the host
Consume, store
and distribute
energy
Mediate
physiologically
important
chemical
transformations
Self-
maintenance
and self-
repair by
means of self-
replication

WHAT ARE THE
FUNCTIONS OF
INTESTINAL
MICROBIOTA?

FUNCTIONS OF INTESTINAL MICROBIOTA

•Due to the altered
microbiota, the child
becomes atopic?
•Being atopic, has
changed its
microbiota?

Does the use of pre, pro or
symbiotics in childhood or even
early in pregnancy could favor a
process of immune regulation
and less development of
chronic inflammatory (allergic
or autoimmune) diseases?

LESSON PLAN
•Concepts
•Theoretical basis
•Clinical applicability
–Immune regulation
–Allergic Diseases
•Prevention
•Treatment

FACTORS GOVERNING THE COLONIZATION AND
STABILITY OF INTESTINAL MICROBIOTA

Pediatria (São Paulo) 28 (2):117, 2006
INTESTINAL
IMMUNE
SYSTEM
IMMUNE
REGULATION

IMMUNOLOGY OF PREGNANCY
Th2 RESPONSE
PLACENTAL CELLS
Treg PROFILE
Th1 RESPONSE DECREASED

IMMUNOLOGY OF PREGNANCY
Th2 RESPONSE AMPLIFIED
Th1 RESPONSE GREATLY DECREASED
Early T cell development is different in allergic children?

“We don’t yet know what
is causing these differences,
but these works confirmed that
abnormal immune development
begins much earlier than previously
suspected, and even before birth”
Susan Prescott

Microbiota/Probiotics
TLrs
Transcription
factors

•STp  peptide from Lactobacillus
•Stimulates IL-10 production by dendritic cells
•Absent in patients with IBD  biomarker for homeostasis
•Future: “Nutraceuticals products”

Stress X Immune Response
CORTISOL
ANXIETY
STRESS
↑RISK OF
INFECTION
IMMUNE RESPONSE
L. casei
defensis
↓RISK OF
INFECTION
Marcos, A. Eur J Nutr. 2004. 43: 381-9

LESSON PLAN
•Concepts
•Theoretical basis
•Clinical applicability
–Immune regulation
–Allergic Diseases
•Prevention
•Treatment

•Pregnancy:
•Placebo or Lactobacillus GG (1 x 10
10
UFC)
•2 to 4 weeks before delivery
•After delivery:
• Exclusively breast feeding  Mother
(Pb or LGG) or children (Pb or LGG) for 6 months

•Coorte  Isolauri and cols.
(Lancet 2001)
•After 7 years: risk for eczema
was significantly lower in the
LGG group
•42,6% x 66,1%;
•RR, 0,64; 95% CI, 0,45-0,92
•SPT  7 years: (ns)
•LGG: 32%
•Pb: 33%

• Rhinitis group: number of episodes/year
• Intervenction: 3.2 (2.4-4.1)
• Control: 4.8 (3.5-6.1)
• Difference: 1.6 episode/year (p=0,04)
• Time for immune
modulation?
• End point (ns)
• loss of adherence?
• 80%59,9%
• 80%68%
N=187 (92 i/95 c)
Age: 2-5 years

The gut microbiota shapes intestinal immune responses
during health and disease
June L. Round
1
& Sarkis K. Mazmanian
1


9, 313-323 (May 2009)

FACTORS THAT INFLUENCE THE
DEVELOPMENT OF ALLERGIC DISEASES
MUCOSAL/
EPITHELIAL
INTESTINAL
MICROBIOTA /
PROBIOTICS
NERVOUS
SYSTEM
IMMUNE
SYSTEM
GENETICS ENVIRONMENT
MATERNAL-FETAL
INTERACTION
CLINICAL
EXPRESSION
OF THE
DISEASE
Kalliomaki et al. J Nutr. 2010; 140: 713s-721s
epigenetics

Twentieth century was of Antibiotics
506,706 publications (8% Reviews)
Rijkers GT et al. J. Nutr (2010), 140: 671S- 676S
Bacillus Lactobacillus
Bifidobacterias Saccharomyces (Fungus)
XXI Century is of Probiotics
15,466 (28% Reviews)

DID YOU EAT YOUR BACTERIA TODAY?
[email protected]